Drug

Tetanus Toxoid

In clinical development

Emerging researchLate-stage development

Also known as Adacel, Bacillus tetani whole, Boostrix, CLOSTRIDIUM TETANI+19 more

Adacel, Bacillus tetani whole, Boostrix, CLOSTRIDIUM TETANI, CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), Certiva, Daptacel, Decavac (Td), Infanrix, Kinrix, Omnihib, PEDIARIX, Pentacel, Quadracel, TDVAX, TETANUS TOXOID ADSORBED, Tenivac, Tetanus-Diphtheria Toxoids, Adult (Td), Vaxelis, tetanus, tetanus toxoid vaccine, inactivated, tetanus toxoid, adsorbed, Pentacel (DTaP-IPV/Hib).

RxNorm798306 ChEMBLCHEMBL2108875 ATCJ07AM51 ATCJ07AM01 ATCJ07AM52UNIIK3W1N8YP13

Research papers

Latest activity

beta

Recent clinical, regulatory, research and industry developments relating to this drug.

A Randomized, Double-Blind, Controlled, Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants

Clinical trial2026-03-30Completed · ClinicalTrials.gov

A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of GR2001 Injection in Healthy Subjects

Clinical trial2024-02-19Completed · ClinicalTrials.gov

Anti-Tumor Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed Glioblastoma Multiforme During Recovery From Therapeutic Temozolomide-induced Lymphopenia

Clinical trial2022-06-01Completed · ClinicalTrials.gov

Transfer of Donor-Derived Humoral Immunity Following Allogeneic Hematopoietic Stem Cell Transplantation

Clinical trial2020-04-21Results posted · ClinicalTrials.gov

Routine vs. Clinically-Directed Antibiotic Treatment in Snake Bite With Local Envenomation: a Randomised Controlled Trial

Clinical trial2020-03-31Terminated · ClinicalTrials.gov

A Randomized, Controlled, Double-blind, Phase 3 Trial to Evaluate the Effects of Maternal or Neonatal Pneumococcal Conjugate Vaccination on Pneumococcal Carriage in Infants up to Nine Months of Age - The PROPEL Trial

Clinical trial2019-02-19Primary completion · ClinicalTrials.gov

Pilot Phase II Study of Safety and Immunogenicity of an ALVAC-CEA/B7.1 Vaccine Administered With Chemotherapy, Alone or in Combination With Tetanus Toxoid, as Compared to Chemotherapy Alone, in Patients With Metastatic Colorectal Adenocarcinoma

Clinical trial2014-01-06Status unknown · ClinicalTrials.gov

CPG 7909 Oligodeoxynucleotides (ODNS) After Autologous Transplantation to Enhance Immune Reconstitution

Clinical trial2010-05-01Terminated · ClinicalTrials.gov

The Effects of Highly Active Antiretroviral Therapy (HAART) on the Recovery of Immune Function in HIV-Infected Children and Young Adults

Clinical trial2006-09-01Completed · ClinicalTrials.gov

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma.

Research1999-12-01The Journal of experimental medicine

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name

Tetanus Toxoid

Aliases & brands

AdacelBacillus tetani wholeBoostrixCLOSTRIDIUM TETANICLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)CertivaDaptacelDecavac (Td)InfanrixKinrixOmnihibPEDIARIXPentacelQuadracelTDVAXTETANUS TOXOID ADSORBEDTenivacTetanus-Diphtheria Toxoids, Adult (Td)Vaxelistetanustetanus toxoid vaccine, inactivatedtetanus toxoid, adsorbedPentacel (DTaP-IPV/Hib)

RxNorm CUI

798306

ChEMBL ID

CHEMBL2108875

ATC codes

J07AM51J07AM01J07AM52

UNII

K3W1N8YP13

Clinical trials

9 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme

CLINICALTRIALS.GOV · LIVE REGISTRY

registered trials across all phases

LATEST COMPLETION 2026

Late-stage (III+)

Completed

Discontinued

PHASE DISTRIBUTIONn = 9

Phase 12Phase 1 / 22Phase 21Phase 31Phase 41Phase N / A2

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Routine vs. Clinically-Directed Antibiotic Treatment in Snake Bite With Local Envenomation: a Randomised Controlled Trial

TerminatedPH IVJawaharlal Institute of Postgraduate Medical Education & Researchn=662020

Unknown statusPH IIILondon School of Hygiene and Tropical Medicinen=6002020

Recent completions

Trials that read out recently, adding to the completed evidence base.

A Randomized, Double-Blind, Controlled, Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants

CompletedPH I/IISinovac Life Sciences Co., Ltd.n=2552026

CompletedPH I/IIGenrix (Shanghai) Biopharmaceutical Co., Ltd.n=2022024

Anti-Tumor Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed Glioblastoma Multiforme During Recovery From Therapeutic Temozolomide-induced Lymphopenia

CompletedPH IGary Archer Ph.D.n=422022

Transfer of Donor-Derived Humoral Immunity Following Allogeneic Hematopoietic Stem Cell Transplantation

CompletedN/ARobert Krancen=72013

The Effects of Highly Active Antiretroviral Therapy (HAART) on the Recovery of Immune Function in HIV-Infected Children and Young Adults

CompletedN/ANational Institute of Allergy and Infectious Diseases (NIAID)n=812006

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Most influential

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma.

The Journal of experimental medicine · 1999 · 799 cites